| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5897596 | Cytokine | 2013 | 9 Pages |
Abstract
⺠Psoriasis is a Th17-mediated disease. ⺠Currently available psoriasis therapies target TNF-α and IL-12 and IL-23. ⺠Therapies targeting the Th17 pathway are currently in phase 3 studies.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Endocrinology
Authors
Erine A. Kupetsky, Alicia R. Mathers, Laura K. Ferris,